Drug Shortages Aren’t Over. And There’s Little Progress Toward Ending Them

The FDA continues to face challenges in its oversight of drug manufacturing plants overseas due to disruptions related to the COVID-19 pandemic and staff vacancies, according to a report from the U.S. Government Accountability Office published Tuesday.